Catalog Number
ACMA00021209
Product Name
MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene
Category
Organic-Linker Blocks- Other Linker Blocks
IUPAC Name
4,11,17-tribromopentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15(20),16,18-nonaene
Molecular Weight
491.0g/mol
Molecular Formula
C20H11Br3
InChI
InChI=1S/C20H11Br3/c21-10-3-6-15-16(7-10)19-13-4-1-11(22)8-17(13)20(15)18-9-12(23)2-5-14(18)19/h1-9,19-20H
InChI Key
JLTMUKRBITYDEG-UHFFFAOYSA-N
Application
MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene serves a specific purpose. Similar to how Methoxyflurane functions as a clinical anesthetic, MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene has its own distinct application, though not related to anesthesia. While Methoxyflurane is recognized for its high potency and blood solubility, its usage is limited due to the risk of renal toxicity, and its chemical instability results in significant metabolism which generates toxic byproducts. Similarly, MOF&2,6,14-tribromo-9,10-dihydro-9,10-[1,2]benzenoanthracene likely has specific advantages and limitations that define its role and effectiveness in its targeted application.
Compound Is Canonicalized
Yes
Covalently-Bonded Unit Count
1
Defined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Hydrogen Bond Acceptor Count
0
Hydrogen Bond Donor Count
0
Monoisotopic Mass
487.84109g/mol
Number of Layer
1-5 layers
Topological Polar Surface Area
0Ų
Undefined Atom Stereocenter Count
0
Undefined Bond Stereocenter Count
0